Nelson J
Bull N Y Acad Med. 1984; 60(4):374-9.
PMID: 6372913
PMC: 1911780.
Richards D, Heel R, Brogden R, Speight T, Avery G
Drugs. 1984; 27(6):469-527.
PMID: 6329638
DOI: 10.2165/00003495-198427060-00001.
Schaad U
Eur J Pediatr. 1984; 141(3):143-6.
PMID: 6321189
DOI: 10.1007/BF00443211.
Martin E
Eur J Clin Microbiol. 1983; 2(5):509-15.
PMID: 6315428
DOI: 10.1007/BF02013918.
Scheld W
Eur J Clin Microbiol. 1983; 2(5):485-8.
PMID: 6315423
DOI: 10.1007/BF02013913.
Ceftriaxone pharmacokinetics in newborn infants.
McCracken Jr G, Siegel J, Threlkeld N, Thomas M
Antimicrob Agents Chemother. 1983; 23(2):341-3.
PMID: 6301369
PMC: 186052.
DOI: 10.1128/AAC.23.2.341.
Pharmacokinetics of ceftriaxone in pediatric patients with meningitis.
Steele R, Eyre L, Bradsher R, Weinfeld R, Patel I, Spicehandler J
Antimicrob Agents Chemother. 1983; 23(2):191-4.
PMID: 6301362
PMC: 186020.
DOI: 10.1128/AAC.23.2.191.
Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults.
Pollock A, Tee P, Patel I, Spicehandler J, Simberkoff M, Rahal Jr J
Antimicrob Agents Chemother. 1982; 22(5):816-23.
PMID: 6295268
PMC: 185666.
DOI: 10.1128/AAC.22.5.816.
Ceftriaxone: in vitro studies and clinical evaluation.
Gnann Jr J, Goetter W, Elliott A, Cobbs C
Antimicrob Agents Chemother. 1982; 22(1):1-9.
PMID: 6289734
PMC: 183664.
DOI: 10.1128/AAC.22.1.1.
Biliary excretion of amoxycillin and ceftriaxone after intravenous administration in man.
Maudgal D, Maxwell J, Lees L, Wild R
Br J Clin Pharmacol. 1982; 14(2):213-7.
PMID: 6285946
PMC: 1427740.
DOI: 10.1111/j.1365-2125.1982.tb01964.x.
Pharmacokinetics of cefotaxime in newborn infants.
McCracken Jr G, Threlkeld N, Thomas M
Antimicrob Agents Chemother. 1982; 21(4):683-4.
PMID: 6282216
PMC: 181970.
DOI: 10.1128/AAC.21.4.683.
Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.
McCracken Jr G, Nelson J, Grimm L
Antimicrob Agents Chemother. 1982; 21(2):262-7.
PMID: 6280599
PMC: 181870.
DOI: 10.1128/AAC.21.2.262.
Single-dose pharmacokinetics of ceftriaxone in infants and young children.
Schaad U, Stoeckel K
Antimicrob Agents Chemother. 1982; 21(2):248-53.
PMID: 6280597
PMC: 181867.
DOI: 10.1128/AAC.21.2.248.
Pharmacokinetics of ceftriaxone in humans.
Patel I, Chen S, PARSONNET M, Hackman M, Brooks M, Konikoff J
Antimicrob Agents Chemother. 1981; 20(5):634-41.
PMID: 6275779
PMC: 181765.
DOI: 10.1128/AAC.20.5.634.
In vitro susceptibility of Haemophilus influenzae and neisseria gonorrhoeae to Ro 13-9904 in comparison with other beta-lactam antibiotics.
Ng W, Chau P, Arnold K
Antimicrob Agents Chemother. 1981; 19(5):925-6.
PMID: 6271052
PMC: 181544.
DOI: 10.1128/AAC.19.5.925.
In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin.
Beskid G, Christenson J, Cleeland R, DeLorenzo W, TROWN P
Antimicrob Agents Chemother. 1981; 20(2):159-67.
PMID: 6269487
PMC: 181657.
DOI: 10.1128/AAC.20.2.159.
Comparative in vitro activity of ceftriaxone against anaerobic bacteria.
Rolfe R, Finegold S
Antimicrob Agents Chemother. 1982; 22(2):338-41.
PMID: 6100430
PMC: 183738.
DOI: 10.1128/AAC.22.2.338.
Comparative efficacies of ceftriaxone, moxalactam, and ampicillin in experimental Salmonella typhimurium infection.
Anton P, Kemp J, Butler T, Jacobs M
Antimicrob Agents Chemother. 1982; 22(2):312-5.
PMID: 6100426
PMC: 183731.
DOI: 10.1128/AAC.22.2.312.
Comparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitis.
Bryan J, Rocha H, Da Silva H, Taveres A, Sande M, Scheld W
Antimicrob Agents Chemother. 1985; 28(3):361-8.
PMID: 4073858
PMC: 180254.
DOI: 10.1128/AAC.28.3.361.
High performance liquid chromatographic determination of moxalactam in human plasma and cerebrospinal fluid.
Nielsen J, Karlaganis G, von Hattingberg H, Schaad U
Eur J Clin Pharmacol. 1985; 29(2):225-9.
PMID: 3908123
DOI: 10.1007/BF00547427.